Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.

Clinical Trial ID NCT03646019

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03646019

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000 12.86
2 Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006 4.18
3 Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998 3.84
4 Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000 2.02
5 Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 2002 1.96
6 Chest pain in the emergency room: value of the HEART score. Neth Heart J 2008 1.83
7 Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003 1.78
8 Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004 1.53
9 A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol 2013 1.43
10 Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999 1.42
11 Cardioprotective functions of HDLs. J Lipid Res 2013 1.29
12 Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004 1.22
13 Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006 1.06
14 High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J Clin Biochem Nutr 2009 1.05
15 Reduced paraoxonase 1 activity as a marker for severe coronary artery disease. Dis Markers 2013 0.94
16 Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochem Biophys Res Commun 2002 0.94
17 Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease. J Am Coll Cardiol 2006 0.94
18 Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies. Mol Genet Metab 2011 0.92
19 Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016 0.88
20 The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases. J Clin Diagn Res 2013 0.86
21 Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease. Clin Cardiol 2004 0.85
22 Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2015 0.82
23 PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. Int J Cardiol 2003 0.79
24 The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose. Coron Artery Dis 2008 0.78
25 Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes. Exp Clin Cardiol 2005 0.78
26 Serum Paraoxonase (PON1) Activity in North-West Indian Punjabi's with Acute Myocardial Infarction. Indian J Clin Biochem 2012 0.78
27 Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. Int J Cardiovasc Imaging 2014 0.75
28 Association of serum paraoxonase activity and coronary artery calcification. Eur Rev Med Pharmacol Sci 2013 0.75
29 Low serum paraoxonase1 activity levels predict coronary artery disease severity. Oncotarget 2016 0.75
30 Paraoxonase 1 Activity, Lipid Profile, and Atherogenic Indexes Status in Coronary Heart Disease. Rep Biochem Mol Biol 2017 0.75
31 PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease. Oxid Med Cell Longev 2015 0.75
32 The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. Kardiol Pol 2016 0.75
33 Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease. Med Sci Monit 2014 0.75
Next 100